(ABUS) Arbutus Biopharma complete technical analysis [charts+indicators] | Buy/Sell Arbutus Biopharma | (ABUS) share price targets
Complete technical analysis of Arbutus Biopharma (ABUS) by charts plus indicators, forecast predictions and share price targets for Arbutus Biopharma (ABUS)
Arbutus Biopharma trades in USA in Health Care sector.
Showing technical analysis as on 2024-08-06 View latest technical analysis
10 day averaged volume of Arbutus Biopharma is 897510
| Date | Daily Closing Price | Open | High | Low | Volume |
| 06 Tue Aug 2024 | 3.62 | 3.57 | 3.69 | 3.50 | 0.697 times |
| 05 Mon Aug 2024 | 3.62 | 3.34 | 3.63 | 3.30 | 1.6 times |
| 02 Fri Aug 2024 | 3.74 | 3.69 | 3.82 | 3.65 | 0.724 times |
| 01 Thu Aug 2024 | 3.81 | 3.64 | 3.84 | 3.35 | 1.428 times |
| 31 Wed Jul 2024 | 3.77 | 3.83 | 3.89 | 3.73 | 1.066 times |
| 30 Tue Jul 2024 | 3.79 | 3.75 | 3.83 | 3.71 | 0.879 times |
| 29 Mon Jul 2024 | 3.78 | 3.91 | 3.91 | 3.71 | 0.923 times |
| 26 Fri Jul 2024 | 3.90 | 3.98 | 3.98 | 3.86 | 0.813 times |
| 25 Thu Jul 2024 | 3.92 | 3.90 | 3.98 | 3.86 | 1.017 times |
| 24 Wed Jul 2024 | 3.87 | 3.83 | 3.92 | 3.80 | 0.721 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 3.6 as stoploss in an intra day buy trade for a target of 3.74. However, stock will show a bearish move below 3.6.
Share price targets for Arbutus Biopharma (ABUS)
| Target Type | Value |
| Downside Target | 2.30 |
| Downside Target | 2.63 |
| Downside Target | 2.92 |
| Downside Target | 3.05 |
| Downside Target | 3.14 |
| Downside Target | 3.29 |
| Downside Target | 3.44 |
| Downside Target | 3.54 |
| Upside Target | 3.64 |
| Upside Target | 3.84 |
| Upside Target | 3.89 |
| Upside Target | 3.91 |
| Upside Target | 3.98 |
Intraday share price targets for Arbutus Biopharma (ABUS)
| Target Type | Value |
| Downside Intraday Target | 3.38 |
| Downside Intraday Target | 3.15 |
| Upside Intraday Target | 3.77 |
| Upside Intraday Target | 3.93 |
| Downside Intraday Target | 3.54 |
Weekly technical analysis of Arbutus Biopharma (ABUS)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 06 Tue Aug 2024 | 3.62 | 3.34 | 3.69 | 3.30 | 0.458 times |
| 02 Fri Aug 2024 | 3.74 | 3.91 | 3.91 | 3.35 | 1.141 times |
| 26 Fri Jul 2024 | 3.90 | 3.70 | 3.98 | 3.69 | 0.731 times |
| 19 Fri Jul 2024 | 3.69 | 3.54 | 3.89 | 3.54 | 1.006 times |
| 12 Fri Jul 2024 | 3.59 | 3.14 | 3.65 | 3.14 | 4.052 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Arbutus Biopharma (ABUS)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 06 Tue Aug 2024 | 3.62 | 3.64 | 3.84 | 3.30 | 0.191 times |
| 31 Wed Jul 2024 | 3.77 | 3.07 | 3.98 | 3.05 | 0.882 times |
| 28 Fri Jun 2024 | 3.09 | 3.36 | 3.64 | 2.92 | 1.294 times |
| 31 Fri May 2024 | 3.36 | 2.74 | 3.44 | 2.63 | 0.418 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Arbutus Biopharma (ABUS)
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Arbutus Biopharma stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Arbutus Biopharma in short term but the sell signal is initial and weak.
Arbutus Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a buy signal for Arbutus Biopharma in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Arbutus Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.77 and Arbutus Biopharma (ABUS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Arbutus Biopharma (ABUS) stock. Volume based technical analysis of Arbutus Biopharma (ABUS) stock is negative.
Arbutus Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Arbutus Biopharma stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Arbutus Biopharma in short term but the sell signal is initial and weak.
Arbutus Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a buy signal for Arbutus Biopharma in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Arbutus Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.77 and Arbutus Biopharma (ABUS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Arbutus Biopharma (ABUS) stock. Volume based technical analysis of Arbutus Biopharma (ABUS) stock is negative.
Arbutus Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.